Dastgheib S, Sayad S, Azizi S, Hajizadeh N, Asadian F, Karimi-Zarchi M
Asian Pac J Cancer Prev. 2024; 25(1):43-55.
PMID: 38285766
PMC: 10911734.
DOI: 10.31557/APJCP.2024.25.1.43.
Yu J, Wang C
Front Oncol. 2023; 13:1047336.
PMID: 36761956
PMC: 9903134.
DOI: 10.3389/fonc.2023.1047336.
Yang H, Wei Y, Zhang Q, Yang Y, Bi X, Yang L
Mol Med Rep. 2022; 26(2).
PMID: 35713220
PMC: 9309539.
DOI: 10.3892/mmr.2022.12774.
Rajagopal T, Seshachalam A, Rathnam K, Talluri S, Venkatabalasubramanian S, Rao Dunna N
PLoS One. 2022; 17(1):e0259761.
PMID: 35061678
PMC: 8782413.
DOI: 10.1371/journal.pone.0259761.
Kim J, Hong Y
Int J Environ Res Public Health. 2020; 17(8).
PMID: 32316696
PMC: 7216258.
DOI: 10.3390/ijerph17082794.
Associations between XRCC3 Thr241Met polymorphisms and breast cancer risk: systematic-review and meta-analysis of 55 case-control studies.
Dashti S, Taherian-Esfahani Z, Keshtkar A, Ghafouri-Fard S
BMC Med Genet. 2019; 20(1):79.
PMID: 31077156
PMC: 6511159.
DOI: 10.1186/s12881-019-0809-8.
Genetic determinants of sporadic breast cancer in Sri Lankan women.
Sirisena N, Adeyemo A, Kuruppu A, Neththikumara N, Samaranayake N, Dissanayake V
BMC Cancer. 2018; 18(1):180.
PMID: 29433565
PMC: 5809862.
DOI: 10.1186/s12885-018-4112-4.
Haplotype analysis of XRCC2 gene polymorphisms and association with increased risk of head and neck cancer.
Saeed S, Mahjabeen I, Sarwar R, Bashir K, Kayani M
Sci Rep. 2017; 7(1):13210.
PMID: 29038438
PMC: 5643489.
DOI: 10.1038/s41598-017-13461-6.
Association of XRCC2 rs3218536 Polymorphism with Susceptibility of Breast and Ovarian Cancer: A Systematic Review and Meta-Analysis.
Kamali M, Hamadani S, Neamatzadeh H, Mazaheri M, Shehneh M, Modaress Gilani M
Asian Pac J Cancer Prev. 2017; 18(7):1743-1749.
PMID: 28749098
PMC: 5648374.
DOI: 10.22034/APJCP.2017.18.7.1743.
Analysis of and gene polymorphisms in pancreatic cancer.
Talar-Wojnarowska R, Gasiorowska A, Olakowski M, Dranka-Bojarowska D, Lampe P, Smolarz B
Biomed Rep. 2016; 4(2):236-240.
PMID: 26893845
PMC: 4734170.
DOI: 10.3892/br.2015.550.
Polymorphisms in RAD51 and their relation with breast cancer in Saudi females.
Tulbah S, Alabdulkarim H, Alanazi M, Reddy Parine N, Shaik J, Pathan A
Onco Targets Ther. 2016; 9:269-77.
PMID: 26834486
PMC: 4716748.
DOI: 10.2147/OTT.S93343.
Lack of an association between XRCC2 R188H polymorphisms and breast cancer: an update meta-analysis involving 35,422 subjects.
Kong B, Lv Z, Chen L, Shen R, Jin L, Yang Z
Int J Clin Exp Med. 2015; 8(9):15808-14.
PMID: 26629080
PMC: 4658969.
Association between x-ray repair cross-complementing group 3 (XRCC3) genetic polymorphisms and papillary thyroid cancer susceptibility in a Chinese Han population.
Yuan K, Huo M, Sun Y, Wu H, Chen H, Wang Y
Tumour Biol. 2015; 37(1):979-87.
PMID: 26264616
DOI: 10.1007/s13277-015-3882-4.
RAD51 135G>C substitution increases breast cancer risk in an ethnic-specific manner: a meta-analysis on 21,236 cases and 19,407 controls.
Sekhar D, Pooja S, Kumar S, Rajender S
Sci Rep. 2015; 5:11588.
PMID: 26108708
PMC: 4479800.
DOI: 10.1038/srep11588.
Association between RAD51 polymorphism and breast cancer susceptibility: a meta analysis.
Li W, Liu K, Song J, Song R, Liu Z
Int J Clin Exp Med. 2015; 8(2):2326-33.
PMID: 25932169
PMC: 4402816.
Polymorphisms in DNA repair genes XRCC2 and XRCC3 risk of gastric cancer in Turkey.
Gok I, Baday M, Cetinkunar S, Kilic K, Caglar Bilgin B
Bosn J Basic Med Sci. 2014; 14(4):214-8.
PMID: 25428673
PMC: 4333970.
DOI: 10.17305/bjbms.2014.4.7.
Association between single nucleotide polymorphisms (SNPs) of XRCC2 and XRCC3 homologous recombination repair genes and triple-negative breast cancer in Polish women.
Smolarz B, Makowska M, Samulak D, Michalska M, Mojs E, Wilczak M
Clin Exp Med. 2014; 15(2):151-7.
PMID: 24728564
PMC: 4544483.
DOI: 10.1007/s10238-014-0284-7.
Impact of XRCC2 Arg188His polymorphism on cancer susceptibility: a meta-analysis.
He Y, Zhang Y, Jin C, Deng X, Wei M, Wu Q
PLoS One. 2014; 9(3):e91202.
PMID: 24621646
PMC: 3951328.
DOI: 10.1371/journal.pone.0091202.
The Arg188His polymorphism in the XRCC2 gene and the risk of cancer.
Zhang Y, Wang H, Peng Y, Liu Y, Xiong T, Xue P
Tumour Biol. 2014; 35(4):3541-9.
PMID: 24414483
DOI: 10.1007/s13277-013-1468-6.
Association between the RAD51 135 G>C polymorphism and risk of cancer: a meta-analysis of 19,068 cases and 22,630 controls.
Wang W, Li J, He X, Li A, Cai Y, Xu N
PLoS One. 2013; 8(9):e75153.
PMID: 24040396
PMC: 3767694.
DOI: 10.1371/journal.pone.0075153.
